BioAge Labs, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| RUBIN PAUL D | Chief Medical Officer | Option Exercise | 18,000 | $6.57 | $118,260 | 18,000 | Dec 9, 2025 |
| RUBIN PAUL D | Chief Medical Officer | Sale | 68,897 | $10.19 | $702,060 | — | Dec 4, 2025 |
| Pande Vijay Satyanand | — | Purchase | 25,306 | $19.90 | $503,589 | 1,119,195 | Oct 1, 2024 |
| Hemrajani Rekha | — | Purchase | 3,000 | $18.00 | $54,000 | 3,000 | Sep 27, 2024 |
| Barton Shane | Principal Accounting Officer | Purchase | 2,632 | $18.00 | $47,376 | 2,632 | Sep 27, 2024 |
| Chen Bihua | — | C | 1,179,529 | — | — | 1,179,529 | Sep 27, 2024 |
| Pande Vijay Satyanand | — | C | 655,294 | — | — | 655,294 | Sep 27, 2024 |
| ENRIGHT PATRICK G | — | Purchase | 400,000 | $18.00 | $7,200,000 | 1,710,589 | Sep 27, 2024 |
| HEALY JAMES | — | Purchase | 11,113 | $18.00 | $200,034 | 11,113 | Sep 27, 2024 |